Elevation of serum interleukin-1 receptor antagonist levels in women with gynaecological cancers

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 12, 1997, Pages 1407-1408

  Fujiwaki, Ritsuto ^a   Hata, Toshiyuki ^b   Miyazaki, Kohji ^b   Kawamura, Takae ^c   Inada, Katsuya ^c  

^a Department of Cardiology   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ARTICLE; CLINICAL ARTICLE; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-1; OVARIAN NEOPLASMS; RECEPTORS, INTERLEUKIN-1; UTERINE CERVICAL NEOPLASMS;

EID: 0030657745     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11012.x     Document Type: Article

References (6)

1. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627–1652.
2. Smith DR, Kunkel SL, Standifold TJ et al. The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma. Am J Pathol 1993; 143: 794–803.
3. Gruss HJ, Dolken G, Brach MA, Mertelsmann R, Herrmann F. High concentration of the interleukin-1 receptor antagonist in serum of patients with Hodgkin’s disease. Lancet 1992; 340: 968.
4. Arend WP, Welgus HG, Thompson RC, Eisenberg SP. Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist. J Clin Invest 1990; 85: 1694–1697.
5. Greer IA, Iyall F, Perera T, Boswell F, Macara LM. Increased concen- trations of cytokines interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction Obstet Gynecol 1994; 84: 937–940.
6. Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ. Human interleukin-1 is a cytocidal factor for several tumor cell lines. J Immunol 1985; 135: 3962–3968.